Cargando…
Polypharmacy-induced cognitive dysfunction and discontinuation of psychotropic medication: a neuropsychological case report
Polypharmacy is common in patients with a diagnosis of bipolar disorder. Although polypharmacy is known to increase the risk of iatrogenic neurological conditions, the recovery of cognitive function after drug withdrawal has been rarely documented in psychiatric patients using standardized neuropsyc...
Autores principales: | Valtonen, Jussi, Karrasch, Mira |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SAGE Publications
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7225781/ https://www.ncbi.nlm.nih.gov/pubmed/32435446 http://dx.doi.org/10.1177/2045125320905734 |
Ejemplares similares
-
How user knowledge of psychotropic drug withdrawal resulted in the development of person-specific tapering medication
por: Groot, Peter C., et al.
Publicado: (2020) -
What I have learnt from helping thousands of people taper off
antidepressants and other psychotropic medications
por: Framer, Adele
Publicado: (2021) -
Clozapine discontinuation withdrawal symptoms in schizophrenia
por: Blackman, Graham, et al.
Publicado: (2021) -
Conversations with clients about antidepressant withdrawal and discontinuation
por: Karter, Justin M.
Publicado: (2020) -
Experiences with benzodiazepine use, tapering, and discontinuation:
an Internet survey
por: Reid Finlayson, Alistair J., et al.
Publicado: (2022)